2013
DOI: 10.2147/ijn.s48694
|View full text |Cite
|
Sign up to set email alerts
|

Local delivery of controlled-release simvastatin/PLGA/HAp microspheres enhances bone repair

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
17
0

Year Published

2014
2014
2022
2022

Publication Types

Select...
10

Relationship

1
9

Authors

Journals

citations
Cited by 35 publications
(17 citation statements)
references
References 39 publications
(71 reference statements)
0
17
0
Order By: Relevance
“…Studies have reported that statins act in the stimulation of bone tissue. 4 , 10 This action occurs due to the stimulation of bone morphogenic protein (BMP-2), which causes osteoblastic proliferation and differentiation, resulting in a greater and better bone tissue formation. According to Anbinder et al, 11 all statins stimulate BMP-2, except pravastatin.…”
Section: Discussionmentioning
confidence: 99%
“…Studies have reported that statins act in the stimulation of bone tissue. 4 , 10 This action occurs due to the stimulation of bone morphogenic protein (BMP-2), which causes osteoblastic proliferation and differentiation, resulting in a greater and better bone tissue formation. According to Anbinder et al, 11 all statins stimulate BMP-2, except pravastatin.…”
Section: Discussionmentioning
confidence: 99%
“…Synthetic polymers are another alternative to naturally derived polymers and have the advantage of being highly modifiable and tunable, though they also lack natural environmental cues to direct tissue growth. Poly(lactic-co-glycolic acid) (PLGA) and poly(lactic acid) are common synthetic polymer carriers for statins, either as microparticles or a membrane [103,124126]. Stein et al combined hydrogel and poly(lactic acid) to locally deliver simvastatin to the lateral aspect of the rat mandible and investigated dose response, finding that a low dose applied locally could achieve bone growth while avoiding the inflammation that occurs with administration of high doses [19].…”
Section: Statins Bone Regeneration and Bone Tissue Engineeringmentioning
confidence: 99%
“…Several in vitro studies indicated that statins can increase the expression of osteogenic marker genes other than BMP-2, including alkaline phosphatase, runt-related transcription factor 2 (RUNX-2), osteopontin, and osteocalcin, in osteoblastic cells and bone marrow-derived cells [17,18]. We demonstrated an effect of controlled release of simvastatin (SIM) from poly (lactic-co-glycolic acid)/hydroxyapatite) (PLGA/HAp) microspheres in vitro and improved bone healing of necrotic bone grafts in vivo [19,20]. We concluded that calcium phosphate bioceramics combined with simvastatin (SIM) microcarriers can stimulate osteogenic differentiation of stem cells in vitro and bone induction in vivo.…”
Section: Introductionmentioning
confidence: 99%